*PEOPLE: ChromaDex Appoints New CSO
A nutraceutical company with HQ in Irvine announced today that it appointed a new chief scientific officer/SVP of innovation.
Matthew Roberts brings over 30 years of experience in scientific innovation and product development to ChromaDex.
He’s launched hundreds of products while building global R&D teams, most recently at Pharmavite, a consumer-packaged goods company which manufactures the Nature Made line of vitamins, minerals, and supplements. He served as chief technology & quality officer there.
Previously, Roberts drove growth across the food, nutrition, and agriculture sectors at The Nature’s Bounty Company, Abbott Nutrition, and Nestlé.
He has been on ChromaDex’s scientific advisory board since November 2016.
“I’ve seen first-hand the company’s commitment to apply breakthrough science and product quality to healthy aging,” Roberts said in a press release. “As chief scientific officer, I’m looking forward to building on that foundation to further develop the science, technical excellence and our talented team.”
Roberts holds a Ph.D. in comparative and environmental toxicology from Cornell University and an executive MBA from Washington University in St. Louis.
He serves on the Nutrition Capital Network innovation screening committee and has served on the Corporate Advisory Board of the Cold Spring Harbor Laboratory, which advances biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology.
ChromaDex is a global nutraceutical company devoted to improving the way people age. Its flagship ingredient, Niagen (nicotinamide riboside), sold directly to consumers as Tru Niagen,is backed with clinical and scientific research, as well as “extensive” IP protection.